News

Surveys at 12 cancer centers across the U.S. looked at cannabis usage among cancer patients.

Nanowired cardiac organoids could one day repair hearts instead of just preventing further damage.

LIFT scholars take flight in a new training course for researchers applying for their first NIH R01 grant.

As people with HIV live longer, they are more likely to get cancers that come with age but HIV might complicate treatment.

Local doctors combine community cancer care with access to research through Hollings NCORP-MU.

Scientists at MUSC Hollings Cancer Center think it's possible that CAR-T-cell therapy could be performed without lymphodepleting chemotherapy beforehand.

Three Hollings members – an M.D., a D.D.S. and a Ph.D. – are pooling their expertise to develop a personalized vaccine to prevent oral cancer from returning.

Colbert Lectureship and Faculty Awards and Recognition gathers best of MUSC’s leaders, researchers, educators and clinicians to recognize hard-working efforts.

MUSC Hollings Cancer Center awarded a number of pilot grants through the spring and summer to kickstart research projects on a range of topics.

The Clinical Trialist Training Program offers early-career clinicians the time and know-how to lead clinical trials.